Exicure Inc. - XCUR Net Assets per Single Share

Graphic logo of Exicure (XCUR)

The book value per share dynamics for Exicure, Inc. (XCUR) correlate with the success of the SNA platform in treating rare pathologies and the search for partners. However, management restructuring for survival and the reduction of personnel to a minimum create serious risks. The current book value per share 0.15 reflects today's metric value, helping investors filter out market noise from the actual state of the company's assets.

Exicure, Inc. (XCUR) Equity per Share: for the period 07/04/2022 - 10/27/2026
Manufactured products of Exicure Inc.

Exicure, Inc. (XCUR) is developing a high-tech precision medicine ecosystem based on the SNA platform, where intellectual property forms the foundation of its capitalization. This book value per common share indicator reflects the value of net assets per share, determining the business's liquidation value and the size of the capital's defensive buffer. Investors should use this chart to assess the company's resilience to crises and to mitigate the risks of a deep drawdown.

Competitors of Exicure, Inc. (XCUR)

Tempus AI, Inc. - Accounting Value per Share|QGEN: Book Value per Share|Net Assets per Single Share Ionis Pharmaceuticals IONS|repligen.com (RGEN) - Accounting Value of a Share|Book Value per Share Avidity Biosciences, Inc. (RNA)|Equity per Share CRSP|Net Assets per Single Share Sema4 WGS|Equity per Share Ultragenyx Corp (RARE)|Book Value per Share BEAM (Beam Therapeutics Inc.)|Book Value per Share sarepta.com SRPT|TWST (Twist Bioscience, Inc.) - Book Value per Share|10x Genomics Inc (TXG) - Net Asset Value per Share|Accounting Value per Share Intellia|Stoke Corp (STOK) - Equity per Share|BLFS: Book Value per Share|Net Assets per Share wavelifesciences.com|Book Value per Share MAZE (Maze Therapeutics)|Accounting Value per Share Sionna Therapeutics, Inc. SION|Accounting Value per Share PRME (Prime Medicine Corp)|Taysha Corp - Book Value per Share|Net Assets per Single Share uniQure N.V. (QURE)|MGTX - Accounting Value of a Share|Book Value per Share RGNX|Net Asset Value per Share Solid Biosciences Inc|OCGN - Accounting Value per Share|Accounting Value of a Share PacBio Corp|BNTC (Benitec Biopharma Inc.) - Book Value per Share|Net Assets per Share DSGN (designtx.com)|RCKT - Net Assets per Single Share|Equity per Share 4DMT FDMT|LXEO: Book Value per Share|Korro Bio, Inc. (KRRO) - Accounting Value per Share|Editas Medicine, Inc. - Accounting Value per Share|Net Assets per Share silence-therapeutics.com|Accounting Value per Share ProQR (PRQR)|Equity per Share Codexis Bio|Book Value per Share SGMO (Sangamo)|Accounting Value per Share nautilus.bio NAUT|Accounting Value per Share MGX (Metagenomi, Inc.)|Precision BioSciences Inc. - Book Value per Share|Net Assets per Single Share Generation Bio Corp (GBIO)|BOLD - Accounting Value of a Share|Book Value per Share imunon.com|PHIO (Phio Pharmaceuticals Corp.) - Equity per Share|Net Assets per Single Share Mustang Bio Inc (MBIO)|Equity per Share TransCode|Book Value per Share BNGO|Book Value per Share Applied DNA Sciences Inc (APDN)|BLUE: Book Value per Share|IPA - Net Asset Value per Share|Omega Therapeutics (OMGA) - Accounting Value per Share|OMIC - Equity per Share|Regulus Therapeutics Inc. - Book Value per Share|Syros Pharmaceuticals Inc. (SYRS) - Net Assets per Share|Book Value per Share TBIO|Accounting Value per Share TRACON Pharmaceuticals, Inc (TCON)|Accounting Value per Share UBX